The Trump administration’s mass firings at the U.S. Food and Drug Administration have removed employees critical to reviewing new medicines, setting back years of effort to bring promising treatments to patients more quickly, former and current FDA sources told Reuters
that’s what we need, delays in getting safe and effective medicine to the public